Latest Breaking News On - ஐரோப்பிய ப்ராடக்ட் அணி தலைவர் - Page 1 : comparemela.com

Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors February 09, 2021 07:30 ET | Source: Aquestive Therapeutics, Inc. Aquestive Therapeutics, Inc. Warren, New Jersey, UNITED STATES WARREN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced the appointment of Julie Krop, M.D., Chief Medical Officer of Freeline Therapeutics (NASDAQ: FRLN), and Marco Taglietti, M.D., Director, President and Chief Executive Officer of SCYNEXIS (NASDAQ: SCYX), to the Board of Directors of the Company effective February 10, 2021. Aquestive also announced the resignation of Douglas K. Bratton from the Board

New yorkUnited statesNew jerseyFort worthMarco tagliettiStephanie carringtonDouglask brattonTranscelerate biopharmaKeith kendallJulie kropRegulatory affairs for stryker biotechHead of global researchResearch developmentBoard audit committeeDevelopment for stiefel laboratories incBrown university school of medicine